13F
中

ANRO ALTO NEUROSCIENCE INC

2026Q1 · CUSIP 02157Q109 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
108
Δ holders QoQ
+10
Breadth percentile
Top 29%
Whale holders
59
Δ whales
+10
Inst. holding value
$602M
New positions
24
Closed positions
14
Price momentum (1Q)
+13.2%
Put / Call
1/3

Breadth history (34 quarters)

2024Q2: Δ+7 · h=59 2024Q3: Δ+17 · h=76 2024Q4: Δ+2 · h=78 2025Q1: Δ+6 · h=84 2025Q2: Δ-3 · h=81 2025Q3: Δ-4 · h=77 2025Q4: Δ+21 · h=98 2026Q1: Δ+10 · h=108 2024Q2: holders=59 2024Q3: holders=76 2024Q4: holders=78 2025Q1: holders=84 2025Q2: holders=81 2025Q3: holders=77 2025Q4: holders=98 2026Q1: holders=108 -21 -10.5 +0 +10.5 +21 5384114 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q3 Top 20% -30.7% -36.3%

Options Sentiment

Put holders
1
QoQ: +1
Call holders
3
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.43
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -0.76 2024-06-30: EPS -0.60 2024-09-30: EPS -0.62 2024-12-31: EPS -0.52 2025-03-31: EPS -0.56 2025-06-30: EPS -0.65 2025-09-30: EPS -0.52 2025-12-31: EPS -0.46 2026-03-31: EPS -0.80 -0.88 -0.44 0.00 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)